What's New at CBER

What's New at CBER You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA) The following links have been updated recently: Posted: 10/12/2021 October 8, 2021 Approval Letter - OBIZUR BK210620 - BloodRelay 1.1.0 CBER Vacancy: Staff Fellow - Pharmacology/Toxicology Reviewer

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA